John T. McDevitt

Dr. John T. McDevitt is a pioneer in the development of the Programmable Bio-Nano-Chip (p-BNC) sensor systems. This universal mHealth platform technology has a capacity to digitize biological signatures for a broad range of key health conditions. These powerful mini-detection ensembles with multiplexed and multi-class (cellular, genomic, proteomic) capabilities have been developed and validated in the context of cancer diagnostics, cardiovascular disease, saliva-based diagnostics, infectious diseases, drugs of abuse detection and cell imaging systems. Further, over the past 5 years the McDevitt laboratory has secured an in-depth experience with management and execution of international, multi-site clinical trials that have resulted in the collection of unique databases using these p-BNC tools. These chip-based sensors have laid the foundation for the efficient collection of first-in-kind wellness and disease signatures for the areas of adjunctive oral cancer tests as well as for cardiac wellness profiles. McDevitt has displayed a strong track record of translating essential bioscience discoveries into real-world clinical practice. He serves as the Scientific Founder and Chief Scientific Officer for SensoDx, LLC. a diagnostic company committed to development of affordable medical microdevice technologies.

Dr. McDevitt currently serves as the Chair for the Biomaterials Department at New York University’s College of Dentistry. McDevitt and his team over the past decade have raised over $25M in Federal and Foundation support. His recent research has been sponsored by major programs funded by the National Institute of Dental and Craniofacial Research (NIDCR) division of the National Institutes of Health (NIH), the Bill and Melinda Gates Foundation, Cancer Prevention Research Institute of Texas (CPRIT), the National Aeronautics and Space Administration (NASA) and the United Kingdom’s Home Office Scientific Development Branch. McDevitt and his team have written more than 185 peer-reviewed scientific manuscripts and have contributed to more than 100 patents and patent applications. In addition to the “2016 AACC Wallace H. Coulter Lectureship Award”, this work was recognized with the “Best of What's New Award” in the Medical Device Category for 2008 by Popular Science as well as for the “Best Scientific Advances Award” in 1998 by the Science Coalition. Dr. McDevitt’s individual honors include the Presidential Young Investigator Award, the 2010 California Polytechnic Distinguished Alumni Award and the Exxon Education Award. Over the past 5 years Dr. McDevitt has served as the Principal Investigator for 6 major clinical trials and 2 clinical pilot studies, all involving the p-BNC system.

  • 19,586 Affection
  • 212,925 Photo Views
  • 219 Following
  • New York City, New York, USA